Inhibition of insulin- and insulin-like growth factor-I-stimulated growth of human breast cancer cells by 1,25-dihydroxyvitamin D3 and the vitamin D3 analogue EB1089
- 1 May 1996
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 32 (5) , 842-848
- https://doi.org/10.1016/0959-8049(95)00647-8
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Vitamin D analogues: from molecule to clinical applicationClinical Endocrinology, 1994
- Detection of insulin-like growth factor binding proteins (IGFBPs) by ligand blotting in breast cancer tissuesCancer Letters, 1994
- Expression of insulin‐like growth factor binding proteins in human breast cancer correlates with estrogen receptor statusJournal of Cellular Biochemistry, 1993
- 1α-hydroxyvitamin D3, hypercalcemia, and growth suppression of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumorsBreast Cancer Research and Treatment, 1992
- The insulin-like growth factor binding proteins (IGFBPs) in human breast cancerBreast Cancer Research and Treatment, 1992
- Regulation of breast cancer growth by insulin-like growth factorsThe Journal of Steroid Biochemistry and Molecular Biology, 1990
- The Role of the Vitamin D Endocrine System in Health and DiseaseNew England Journal of Medicine, 1989
- POSSIBLE ROLE FOR VITAMIN D IN CONTROLLING BREAST CANCER CELL PROLIFERATIONThe Lancet, 1989
- Autocrine and paracrine growth regulation of human breast cancerJournal of Steroid Biochemistry, 1986
- 1,25-Dihydroxyvitamin D3 inhibitory effect on the growth of two human breast cancer cell lines (MCF-7, BT-20)Journal of Steroid Biochemistry, 1986